Key Australian Patent for Recces Broad-Spectrum Antibiotics
Filed with ASX · · 2 pages · English
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Update on Progress of Broad Spectrum Antibiotic RECCE 327
- Update on meeting with US FDA
- Additional AU$861,590 R&D Tax Incentive Rebate Received
- Recce Half Yearly Report and Appendix 4D
- Data Submission & Further Communication Request with US FDA
Later from Recce Pharmaceuticals
- Change of Registry Address: Automic P/L - Sydney Office
- Recce Successfully Raises $1.8 million via Placement
- USA Patent Granted for Recces Antibiotics
- Appointment of Independent Chair and Additional Director
- Appendix 4C and commentary
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals